ACOR

Acorda Therapeutics News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Acorda Therapeutics Inc ACOR NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-1.49 -21.98% 5.29 19:58:28
Open Price Low Price High Price Close Price Prev Close
5.91 4.86 6.20 5.22 6.78
more quote information »

Recent News

Date Time Source Heading
3/04/202116:38SEEKAcorda shares volatile on Q4 results, 2021 forecast
3/04/202116:05SEEKAcorda Therapeutics EPS misses by $1.02, beats on revenue
3/04/202116:03EDGARCurrent Report Filing (8-k)
3/04/202116:01BWAcorda Therapeutics Provides Business Update and Reports..
2/25/202107:00BWAcorda Fourth Quarter/Year End 2020 Update:..
2/19/202108:55SEEKAcorda Therapeutics business chief retires
2/19/202107:04EDGARCurrent Report Filing (8-k)
2/19/202107:00BWAcorda Therapeutics Announces Departure of Chief, Business..
2/17/202107:50EDGARCurrent Report Filing (8-k)
2/16/202116:22EDGARAmended Statement of Ownership (sc 13g/a)
2/16/202115:56EDGARAmended Statement of Ownership (sc 13g/a)
2/16/202115:11EDGARAmended Statement of Ownership (sc 13g/a)
2/16/202110:41EDGARStatement of Ownership (sc 13g)
2/12/202107:46EDGARAmended Statement of Ownership (sc 13g/a)
2/11/202110:25EDGARAmended Statement of Ownership (sc 13g/a)
2/11/202107:00BWAcorda Therapeutics Announces Completion of Sale of..
2/10/202114:49EDGARAmended Statement of Ownership (sc 13g/a)
1/15/202120:19TRMNAcorda Stock at $35 a Share? This Analyst Thinks It’s..
1/13/202107:31EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
1/13/202107:13EDGARCurrent Report Filing (8-k)
1/12/202116:07BWAcorda Therapeutics to Present at 39th Annual J.P. Morgan..
1/11/202116:20BWAcorda Therapeutics to Present at H.C. Wainwright BIOCONNECT..
12/31/202016:19BWAcorda Therapeutics Announces Completion of One-for-Six..
12/10/202009:10EDGARAmended Statement of Ownership (sc 13g/a)
12/01/202017:07EDGARCurrent Report Filing (8-k)
11/12/202007:44EDGARStatement of Changes in Beneficial Ownership (4)
11/03/202016:10EDGARCurrent Report Filing (8-k)
11/03/202016:00BWAcorda Reports Third Quarter 2020 Financial Results
10/27/202007:00BWAcorda Third Quarter 2020 Update: Webcast/Conference Call..
10/19/202016:47EDGARCurrent Report Filing (8-k)
10/05/202017:03EDGARCurrent Report Filing (8-k)
9/21/202008:36EDGARStatement of Changes in Beneficial Ownership (4)
9/21/202008:32EDGARStatement of Changes in Beneficial Ownership (4)
9/21/202008:30EDGARStatement of Changes in Beneficial Ownership (4)
9/18/202006:07EDGARNotice of Effectiveness (effect)
9/17/202016:43EDGARProspectus Filed Pursuant to Rule 424(b)(4) (424b4)
9/17/202007:00GLOBEAravive Appoints Michael W. Rogers to Board of Directors
9/11/202014:27EDGARSecurities Registration Statement (simplified Form) (s-3)
9/11/202007:06EDGARSecurities Registration Statement (simplified Form) (s-3)
8/31/202016:40EDGARCurrent Report Filing (8-k)
8/28/202010:01EDGARCurrent Report Filing (8-k)
8/20/202016:07EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
8/17/202016:22EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
8/17/202016:16EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
8/10/202016:05EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
8/10/202009:26EDGARAmended Statement of Ownership (sc 13g/a)
8/10/202006:08EDGARQuarterly Report (10-q)
8/04/202017:48EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
8/04/202016:03EDGARCurrent Report Filing (8-k)
8/04/202016:00BWAcorda Reports Second Quarter 2020 Financial Results
See more news about this stock »


Your Recent History
NASDAQ
ACOR
Acorda The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.